Psoriasis, An inflammatory condition associated with oxidative stress

Psoriasis, An inflammatory condition associated with oxidative stress

Background: Psoriasis is a chronic inflammatory skin disease characterized by pathological skin lesions due to various exogenous and endogenous factors. Oxidative stress can be one of the causes for the occurrence of psoriasis as well as significant contributor to its progression. Skin exposure to a...

Full description

Bibliographic Details
Main Authors:	Swati Pal, Sumit Sen, Indrajit Nath, Arun Kumar, Utpal Kumar Biswas
Format:	Article
Language:	English
Published:	Manipal College of Medical Sciences, Pokhara 2021-04-01
Series:	Asian Journal of Medical Sciences
Subjects:	psoriasis oxidative stress malondialdehyde (mda) nitric oxide end product (nox) hs-crp pasi (psoriasis area and severity index)
Online Access:	https://www.nepjol.info/index.php/AJMS/article/view/33343

Similar Items

Study of serum Ceruloplasmin, Malondialdehyde (MDA) and hs-CRP as biomarkers of severity in Psoriasis
by: 1. K Prashanth, Assistant Professor, Department of Biochemistry, Rajiv Gandhi Institute of Medical Sciences [RIMS], Adilabad, Telangana State, India. 2. MohdInayatulla Khan, Assistant Professor, Department of Physiology, Rajiv Gandhi Institute of Medical Sciences [RIMS], Adilabad, Telangana State, India.
Published: (2020-12-01)

PASI (Psoriasis Area and Severity Index) in the evaluation of the clinical manifestations of psoriasis
by: A. A. Kubanov, et al.
Published: (2017-08-01)

Medical Informatics applied in psoriasis diagnosis and management
by: Hangan L.T., et al.
Published: (2016-05-01)

PASI and PQOL-12 score in psoriasis : Is there any correlation?
by: Vikas Shankar, et al.
Published: (2011-01-01)

Plasma homocysteine levels in patients with Psoriasis
by: Mousumi Das
Published: (2017-08-01)

Myeloperoxidase Inhibition Ameliorates Plaque Psoriasis in Mice
by: Savannah D. Neu, et al.
Published: (2021-08-01)

Relationship of Staphylococcal Aureus Colonization with Severity of Psoriasis Vulgaris Disease According to PASI Score
by: A. Darjani, et al.
Published: (2014-01-01)

A Six-Year Analysis of Biological Therapy for Severe Psoriasis in a Lithuanian Reference Centre of Dermatovenereology
by: Tadas Raudonis, et al.
Published: (2020-06-01)

Comparative Role of Topical Betamethasone Valerate with Topical Calcipotriol in Mild and Moderate Plaque Type Psoriasis
by: Sana Imran, et al.
Published: (2014-08-01)

Use of Guselkumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A 1 Year Real-Life Study
by: Marco Galluzzo, et al.
Published: (2020-07-01)

Facial psoriasis in a mask-like distribution
by: Cameron M.B. Zachary, MS, et al.
Published: (2021-01-01)

Psoriasis can markedly impair the quality of life of patients irrespective of severity: Results of a hospital-based cross-sectional study
by: Ajith Vettuparambil, et al.
Published: (2016-01-01)

Evaluation of therapeutic response of methotrexate and calcipotriol combination compared with methotrexate alone in plaque psoriasis
by: Deepthi Vasanthada, et al.
Published: (2014-04-01)

Practical experience of ustekinumab in patients with moderate-to-severe psoriasis who had inadequate therapeutic response to previous tumor necrosis factor blockers
by: Tzu-Chang Wang, et al.
Published: (2015-03-01)

Correlation Between Dermatology Life Quality Index and Psoriasis Area and Severity Index in Patients with Psoriasis Treated with Ustekinumab
by: Jeanette Halskou Hesselvig, et al.
Published: (2017-12-01)

Ustekinumab Efficacy and Safety in Children with Plaque, Erythrodermic and Palmoplanar Forms of Psoriasis: Retrospective Cohort Study
by: Nikolay N. Murashkin, et al.
Published: (2020-12-01)

Psoriasis: Correlation between severity index (PASI) and quality of life index (DLQI) based on the type of treatment
by: Ali Al Raddadi, et al.
Published: (2016-01-01)

Effect of Disease Severity on the Quality of Life and Sense of Stigmatization in Psoriatics
by: Kowalewska B, et al.
Published: (2021-02-01)

Single-center, noninterventional clinical trial to assess the safety, efficacy, and tolerability of a dimeticone-based medical device in facilitating the removal of scales after topical application in patients with psoriasis corporis or psoriasis capitis
by: Hengge UR, et al.
Published: (2017-06-01)

Audiological evaluation in patients with psoriasis
by: Maha Elsayed Ahmed, et al.
Published: (2021-01-01)

Assessing the Impact of Improvements in PASI and Itch Scores on Patients’ Quality of Life in the Treatment of Psoriasis
by: Gil Yosipovitch, et al.
Published: (2019-07-01)

CD19+ B cell subsets in the peripheral blood and skin lesions of psoriasis patients and their correlations with disease severity
by: J. Lu, et al.
Published: (2016-01-01)

Evaluating Serum Levels of IL-33, IL-36, IL-37 and Gene Expression of IL-37 in Patients with Psoriasis Vulgaris
by: Mojtaba Sehat, et al.
Published: (2018-04-01)

Interobserver variation of psoriasis area and severity index in a clinical setting
by: Neema Sandra Dias, et al.
Published: (2020-01-01)

Associations between body mass index and severity of psoriasis
by: Sobhan M, et al.
Published: (2017-11-01)

Quality of life and severity of skin changes in the dynamics of psoriasis
by: Krzysztof Owczarek, et al.
Published: (2016-05-01)

Psoriazisin klinik şiddeti ile histopatolojik bulgular arasında ilişki var mıdır? klinikopatolojik bir çalışma
by: Figen ASLAN
Published: (2019-06-01)

The Serum Levels of Malondialdehyde, Vitamin E and Erythrocyte Catalase Activity in Psoriasis Patients
by: Vijaykumar M. Pujari, et al.
Published: (2014-11-01)

Alteration in lipid profile and lipid indices as cardiometabolic risk markers in psoriasis
by: Neela Mannangi, et al.
Published: (2020-01-01)

Response to Biologics During the First Six Months of Therapy in Biologic-naïve Patients with Psoriasis Predicts Risk of Disease Flares: A Danish Nationwide Study
by: Nikolai Loft, et al.
Published: (2021-01-01)

Early detection of subclinical lower limb enthesopathy by ultrasonography in patients with psoriasis: Relation to disease severity
by: Safaa A. Hussein, et al.
Published: (2021-04-01)

Magnetic resonance imaging (MRI) evidence of sacroiliitis in skin psoriasis patients: Relation to disease severity
by: Nevine Dorgham, et al.
Published: (2021-06-01)

Experience of Phototherapy in Dermatological Praxis in Complex Therapy of Psoriasis Patients
by: Hartmane Ilona, et al.
Published: (2016-02-01)

Clinical evaluation of different therapeutic modalities in psoriasis by Pasi score
by: Neerja Puri, et al.
Published: (2013-01-01)

A STUDY ON TOPICAL CALCIUM DOBESILATE FOR THE TREATMENT OF LIMITED PLAQUE PSORIASIS
by: Neerja Puri, et al.
Published: (2013-07-01)

A study of clinical and biochemical correlation in patients of psoriasis in acute exacerbation
by: Neerja Puri, et al.
Published: (2014-04-01)

Contribution of myeloperoxidase and inducible nitric oxide synthase to pathogenesis of psoriasis
by: Nursel Dilek, et al.
Published: (2016-12-01)

Role of Oxidative Stress in various stages of Psoriasis
by: Fearoz Khan, et al.
Published: (2020-12-01)

The Psoriasis Area and Severity Index Is the Adequate Criterion to Define Severity in Chronic Plaque-Type Psoriasis
by: Schmitt, Jochen, et al.
Published: (2014)

Correlation of Disease Activity and Quality of Life of Patients with Psoriasis after Narrow-band Ultraviolet B Therapy
by: Lyubomir A. Dourmishev, et al.
Published: (2020-03-01)